Argent Trust Co’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $6.78M | Buy |
31,999
+1,510
| +5% | +$296K | 0.2% | 120 |
|
|
2026
Q1 | $5.98M | Buy |
30,489
+630
| +2% | +$122K | 0.2% | 119 |
|
|
2025
Q4 | $5.18M | Buy |
29,859
+355
| +1% | +$64.6K | 0.18% | 122 |
|
|
2025
Q3 | $5.62M | Sell |
29,504
-2,392
| -7% | -$424K | 0.2% | 110 |
|
|
2025
Q2 | $5.73M | Buy |
31,896
+251
| +0.8% | +$43.6K | 0.22% | 100 |
|
|
2025
Q1 | $5.35M | Buy |
31,645
+311
| +1% | +$51.1K | 0.22% | 96 |
|
|
2024
Q4 | $4.73M | Buy |
31,334
+145
| +0.5% | +$22.6K | 0.19% | 105 |
|
|
2024
Q3 | $4.84M | Sell |
31,189
-1,059
| -3% | -$158K | 0.2% | 104 |
|
|
2024
Q2 | $4.41M | Sell |
32,248
-269
| -0.8% | -$36.8K | 0.19% | 106 |
|
|
2024
Q1 | $4.33M | Sell |
32,517
-3,179
| -9% | -$412K | 0.19% | 111 |
|
|
2023
Q4 | $4.92M | Buy |
35,696
+770
| +2% | +$101K | 0.24% | 93 |
|
|
2023
Q3 | $4.26M | Sell |
34,926
-765
| -2% | -$102K | 0.23% | 95 |
|
|
2023
Q2 | $5.02M | Buy |
35,691
+7,345
| +26% | +$1.01M | 0.27% | 80 |
|
|
2023
Q1 | $4.01M | Buy |
28,346
+1,233
| +5% | +$176K | 0.25% | 90 |
|
|
2022
Q4 | $4.24M | Buy |
27,113
+181
| +0.7% | +$26K | 0.28% | 84 |
|
|
2022
Q3 | $3.3M | Sell |
26,932
-215
| -0.8% | -$28.3K | 0.24% | 93 |
|
|
2022
Q2 | $3.61M | Sell |
27,147
-90
| -0.3% | -$12.3K | 0.25% | 92 |
|
|
2022
Q1 | $3.73M | Buy |
27,237
+374
| +1% | +$52.1K | 0.23% | 101 |
|
|
2021
Q4 | $4.65M | Buy |
26,863
+1,495
| +6% | +$227K | 0.27% | 81 |
|
|
2021
Q3 | $3.69M | Buy |
25,368
+125
| +0.5% | +$18.3K | 0.24% | 103 |
|
|
2021
Q2 | $3.33M | Buy |
25,243
+1,049
| +4% | +$137K | 0.22% | 106 |
|
|
2021
Q1 | $3.1M | Sell |
24,194
-58
| -0.2% | -$7.15K | 0.22% | 105 |
|
|
2020
Q4 | $2.89M | Sell |
24,252
-185
| -0.8% | -$22.6K | 0.22% | 99 |
|
|
2020
Q3 | $2.8M | Sell |
24,437
-125
| -0.5% | -$14.8K | 0.25% | 92 |
|
|
2020
Q2 | $2.8M | Sell |
24,562
-166
| -0.7% | -$17.6K | 0.26% | 90 |
|
|
2020
Q1 | $1.99M | Buy |
24,728
+464
| +2% | +$48K | 0.22% | 107 |
|
|
2019
Q4 | $2.59M | Sell |
24,264
-121
| -0.5% | -$12.6K | 0.23% | 105 |
|
|
2019
Q3 | $2.61M | Sell |
24,385
-65
| -0.3% | -$6.67K | 0.25% | 100 |
|
|
2019
Q2 | $2.49M | Sell |
24,450
-75
| -0.3% | -$7.21K | 0.25% | 100 |
|
|
2019
Q1 | $2.21M | Sell |
24,525
-50
| -0.2% | -$4.33K | 0.23% | 112 |
|
|
2018
Q4 | $2.05M | Buy |
24,575
+653
| +3% | +$61.2K | 0.24% | 105 |
|
|
2018
Q3 | $2.55M | Sell |
23,922
-1,000
| -4% | -$110K | 0.29% | 86 |
|
|
2018
Q2 | $2.74M | Buy |
+24,922
| New | +$2.6M | 0.33% | 77 |
|
Other funds holding DGX
EIG
Argent Trust Co's DGX Position: Q2 2026 in Review
Argent Trust Co increased its Quest Diagnostics (DGX) stake by 5% in Q2 2026, buying an estimated $296K and bringing the position to 31,999 shares worth $6.78M. The position accounts for 0.2% of the portfolio, ranked #120.
Argent Trust Co first reported a position in DGX in Q2 2018 and has held it in 33 quarters since. 1,099 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Argent Trust Co held 31,999 shares of Quest Diagnostics worth $6.78M as of Q2 2026.
- Argent Trust Co bought 1,510 Quest Diagnostics shares in Q2 2026, an estimated $296K.
- Quest Diagnostics made up 0.2% of Argent Trust Co's portfolio in Q2 2026, its #120 holding.
- Argent Trust Co first reported a position in Quest Diagnostics in Q2 2018 and has held it in 33 quarters since.
- 1,099 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Argent Trust Co's 13F filing for Q2 2026, filed 6 Aug 2026.